Deals channel feed – Endpoints News

Deals channel feed

Updated: Lundbeck makes $2.6B cash move for Longboard a month after starting Phase 3 in Dravet syndrome

7 months ago

Catalent sells New Jersey plant to Belgian CDMO, plans moving HQ elsewhere

7 months ago

Sanofi lands on private equity firm CD&R as potential buyer of consumer health unit

7 months ago

Eli Lilly inks another obesity pact, doubling down on small Swiss partner

7 months ago

Sen. Warren urges FTC to ‘carefully scrutinize’ Novo-Catalent deal over competition concerns

7 months ago

AI biotechs Recursion and Exscientia first held deal talks in 2022

7 months ago

Spatial biology companies Vizgen and Ultivue merge amid ongoing lawsuits

7 months ago

AI biotech insitro partners with Lilly on metabolic disease drugs

7 months ago

Kevin Tang's Concentra swoops in on another struggling biotech, offering to buy Kezar

7 months ago

Jim Wilson secures $100M for global approach aimed at reviving gene therapy field

7 months ago

Astellas places new bet on gene therapy in $50M upfront deal with UK startup

7 months ago

Merck partners with small UK biotech to drug fibroblasts for fibrosis, I&I diseases

7 months ago

AstraZeneca makes another cardio deal, betting $100M on China company’s lipid drug

7 months ago

Biotech's third quarter was relatively bright — with a few caveats

7 months ago

Sanofi sells rare disease drug Enjaymo to Recordati for $825M upfront

7 months ago

WuXi companies may sell units impacted by Biosecure — report

7 months ago

Exclusive: Medicare navigation startup Connie Health is buying a Redesign Health-backed rival

7 months ago

CAMP4, preparing for IPO, announces partnership with BioMarin

7 months ago

23andMe CEO says she is no longer open to outside takeover offers

7 months ago

Metsera partners with Amneal to manufacture obesity drugs, and Clive Meanwell hands over CEO role

7 months ago

Updated: Prime Medicine whittles down pipeline, signs gene editing deal with Bristol Myers

7 months ago

Updated: Roche buys Regor’s CDK inhibitors for $850M upfront amid push to develop 20 ‘transformative’ medicines

7 months ago

Instacart partners with 9amHealth to combine weight loss drugs with healthy foods

7 months ago

CSL Seqirus inks fifth contract with BARDA, making the partnership now worth $1.14B

7 months ago

First page Previous page 8 9 101112 13 14 Next page Last page